These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17275581)

  • 1. Physiology of acid-base balance: links with kidney stone prevention.
    Halperin ML; Cheema Dhadli S; Kamel KS
    Semin Nephrol; 2006 Nov; 26(6):441-6. PubMed ID: 17275581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent uric acid stones.
    Kamel KS; Cheema-Dhadli S; Shafiee MA; Davids MR; Halperin ML
    QJM; 2005 Jan; 98(1):57-68. PubMed ID: 15625355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for disordered acid-base handling in calcium stone-forming patients.
    Worcester EM; Bergsland KJ; Gillen DL; Coe FL
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F363-F374. PubMed ID: 31790303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
    Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
    J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones.
    Kıraç M; Küpeli B; Irkilata L; Gülbahar O; Aksakal N; Karaoğlan U; Bozkırlı I
    Kaohsiung J Med Sci; 2013 Feb; 29(2):88-92. PubMed ID: 23347810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and prevention of uric acid stones].
    Ferrari P; Bonny O
    Ther Umsch; 2004 Sep; 61(9):571-4. PubMed ID: 15493118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies to identify the basis for an alkaline urine pH in patients with calcium hydrogen phosphate kidney stones.
    Kamel KS; Shafiee MA; Cheema-Dhadli S; Halperin ML
    Nephrol Dial Transplant; 2007 Feb; 22(2):424-31. PubMed ID: 17107965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sex specific factors in recurrent idiopathic calcium urolithiasis].
    Weitbrecht M; Hegemann M; Pfab R; Wieser T
    Urologe A; 1987 May; 26(3):129-32. PubMed ID: 3603898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary animal protein and urinary supersaturation in renal stone disease.
    Fellström B; Danielson BG; Karlström B; Lithell H; Ljunghall S; Vessby B
    Proc Eur Dial Transplant Assoc; 1983; 20():411-6. PubMed ID: 6657664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of urine pH and citrate concentration on the upper limit of metastability for calcium phosphate.
    Greischar A; Nakagawa Y; Coe FL
    J Urol; 2003 Mar; 169(3):867-70. PubMed ID: 12576801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.